N/A Completed N=4 Basic Science

Effect of Daily Low Dose Aspirin on Exhaled Inflammatory Mediators in Normal Subjects

Healthy

Source: ClinicalTrials.gov NCT00898222 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Nov 2014

Primary outcomePrimary: Change in Exhaled Inflammatory Mediator Levels — 1.42 pg/mL

Summary

Hypothesis: Low dose aspirin does not change exhaled inflammatory breath mediators in normal subjects.

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Exhaled Inflammatory Mediator Levels	1.42	—

Eligibility Criteria

Inclusion Criteria

healthy adults

Exclusion Criteria

any underlying major medical conditions such as heart disease, hypertension, stroke, diabetes, bleeding disorders

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00898222). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.